Myriad Appoints Chip Parkinson As Executive Vice President For Reimbursement Strategy

Myriad Genetics, Inc. has announced that Chip Parkinson will join the company in the newly created position of executive vice president (EVP) for Reimbursement Strategy. In this role, Mr. Parkinson will report to Mark C. Capone, president and CEO of Myriad Genetics with responsibility for facilitating additional global reimbursement for the Company’s pioneering molecular diagnostic products. In his new role, Mr. Parkinson will lead the effort to identify novel approaches to partner with managed care plans and other healthcare payers to ensure that Myriad’s pioneering products deliver value to our customers.

Mr. Parkinson has held several senior positions . . .